Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.36 |
| ▸ | GSK3B | P49841 | 3/20 | 0.36 |
| ▸ | DDX3X | O00571 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 3/20 | 0.34 |
| ▸ | ACACB | O00763 | 2/20 | 0.34 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7222815 | 1.00 | GCK (0.38) | GCKKCNH2DYRK1AGSK3BDDX3X | |
| SCHEMBL7217055 | 0.82 | NPC1 (0.48) | — | |
| SCHEMBL7216469 | 0.80 | NPC1 (0.42) | — | |
| SCHEMBL7216549 | 0.80 | ROCK2 (0.37) | ACACB | |
| SCHEMBL7216812 | 0.78 | NPC1 (0.56) | — | |
| SCHEMBL7216626 | 0.75 | APLNR (0.44) | NAMPT | |
| SCHEMBL6831069 | 0.75 | NAMPT (0.53) | NAMPT | |
| SCHEMBL7216813 | 0.75 | F10 (0.39) | KCNH2 | |
| SCHEMBL7216265 | 0.73 | NPC1 (0.38) | IRAK4 | |
| SCHEMBL6834309 | 0.73 | LMNA (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6653471-B2 | Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction | NEUROGEN CORPORATION | 2003-11-25 | — | — | US | disclosed |